Innovate GBM's 2025 Investment Playbook Year to Date Review: Building a New Market for Brain Cancer Investments and Breakthroughs [Yahoo! Finance]
OSR Holdings, Inc. (OSRH)
Company Research
Source: Yahoo! Finance
of brain tumor research, investment, and treatment, has released its 2025 Year-to-Date Impact Report, showcasing a bold new approach to solving some of oncology's most stubborn and underfunded problems: glioblastoma multiforme (GBM) and other brain tumors. Built in memory of Sanam Thukral, DVM, a young veterinarian who passed away in 2024 following a 30-month battle with GBM, Innovate GBM has grown from a grassroots support group into a globally connected movement accelerating momentum in one of oncology's most neglected fields. Rather than relying on traditional philanthropy or government grants, the organization is executing a c apital markets driven playbook to fuel progress in a field long ignored by mainstream funders. Brain cancer research has too often been slowed by disconnected systems and isolated efforts, while other diseases have moved forward through clearer, more structured pipelines. Through an independent, investor-driven Ecosystem , Innovate GBM is channeling priv
Show less
Read more
Impact Snapshot
Event Time:
OSRH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OSRH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OSRH alerts
High impacting OSR Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
OSRH
News
- Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target Following Major Licensing Agreement [Yahoo! Finance]Yahoo! Finance
- OSR (NASDAQ:OSRH) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months [Yahoo! Finance]Yahoo! Finance
- Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three MonthsPR Newswire
- OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025 [Yahoo! Finance]Yahoo! Finance
OSRH
Sec Filings
- 11/25/25 - Form 8-K
- 11/12/25 - Form 10-Q
- 10/24/25 - Form 3
- OSRH's page on the SEC website